Article Type
Changed
Tue, 03/19/2024 - 15:15

 

Primary biliary cholangitis is a rare progressive autoimmune liver disease that specifically targets biliary epithelial cells. In this article, Dr. Kowdley describes prognostic markers of disease, current and investigational medical therapies, liver transplant, and focusing on maximizing favorable long-term outcomes.

Click Here to Read More

Sponsor
Developed under the direction and sponsorship of Ipsen Biopharmaceuticals
Publications
Sponsor
Developed under the direction and sponsorship of Ipsen Biopharmaceuticals
Sponsor
Developed under the direction and sponsorship of Ipsen Biopharmaceuticals

 

Primary biliary cholangitis is a rare progressive autoimmune liver disease that specifically targets biliary epithelial cells. In this article, Dr. Kowdley describes prognostic markers of disease, current and investigational medical therapies, liver transplant, and focusing on maximizing favorable long-term outcomes.

Click Here to Read More

 

Primary biliary cholangitis is a rare progressive autoimmune liver disease that specifically targets biliary epithelial cells. In this article, Dr. Kowdley describes prognostic markers of disease, current and investigational medical therapies, liver transplant, and focusing on maximizing favorable long-term outcomes.

Click Here to Read More

Publications
Publications
Article Type
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Information from Industry-Sponsored Content
Gate On Date
Wed, 01/17/2024 - 10:00
Un-Gate On Date
Wed, 01/17/2024 - 10:00
Use ProPublica
CFC Schedule Remove Status
Wed, 01/17/2024 - 10:00
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Activity Salesforce Deliverable ID
401491.2